by Green Griffith | Jul 25, 2018 | Firm News, IP News
Green, Griffith & Borg-Breen continues to expand its experienced IP team with the addition of Timothy O’Brien. Green Griffith is pleased to announce the addition of Timothy O’Brien to its Intellectual Property team as an Associate Attorney. Tim graduated with...
by Green Griffith | Jul 24, 2018 | IP News
On July 18, 2018, FDA released an 11-point plan of action which it contends will “encourage innovation and competition among biologics and the development of biosimilars.” Since passage of the Biologics Price Competition and Innovation Act (“BPCIA”) in 2010, FDA has...
by Green Griffith | Jul 12, 2018 | Firm News
Chris was invited to attend the 3rd International IP Skills Summit (IIPSS) in Hyderabad, India, held on June 27-28, 2018. IIPSS is an annual inclusive, collaborative gathering of IP Counsel, Pharma Executives, R&D Leaders and Academicians focused on sharing...
by Green Griffith | Jul 2, 2018 | Firm News
Green Griffith is pleased to announce that Ben Witte has joined our team as an Associate. Ben focuses his practice on patent litigation related to chemical, pharmaceutical, and biotechnology matters. He has particular experience representing pharmaceutical companies...
by Green Griffith | Jun 26, 2018 | Firm News, IP News
Green Griffith successfully defended one of Horizon’s Orange Book-listed patents (U.S. 8,642,012) for its RAVICTI® oral liquid product at the Federal Circuit against Par Pharmaceutical’s appeal of an unsuccessful inter partes review (“IPR”) proceeding. In a decisive...
